Preclinical News and Research

RSS
Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

Investigational treatment combination improves virologic control in SIV-infected monkeys

Investigational treatment combination improves virologic control in SIV-infected monkeys

Clinical study to test safety and ability of investigational Zika vaccine candidate begins

Clinical study to test safety and ability of investigational Zika vaccine candidate begins

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Researchers working on breast-friendly, radiation-free method to detect possible breast cancer

Researchers working on breast-friendly, radiation-free method to detect possible breast cancer

Transcatheter cerebral embolic protection effectively captures embolic debris and safe in TAVR patients

Transcatheter cerebral embolic protection effectively captures embolic debris and safe in TAVR patients

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Fred Hutchinson opens first-of-its-kind clinic to provide new immunotherapies for cancer patients

Researchers identify potential new treatment for brain cancer by targeting genes linked to microcephaly

Researchers identify potential new treatment for brain cancer by targeting genes linked to microcephaly

Stents can be as effective as surgery for many patients with left main coronary artery disease

Stents can be as effective as surgery for many patients with left main coronary artery disease

Heart problems from common cancer treatment can be alleviated by using gene therapy

Heart problems from common cancer treatment can be alleviated by using gene therapy

OCT offers safe and better guidance for patients undergoing PCI to treat coronary artery disease

OCT offers safe and better guidance for patients undergoing PCI to treat coronary artery disease

Turning off TAZ protein in liver cells reverses fibrosis in mice

Turning off TAZ protein in liver cells reverses fibrosis in mice

Biovica, Eisai sign agreement to analyze DiviTum for improved cancer drug assessment in animal models

Biovica, Eisai sign agreement to analyze DiviTum for improved cancer drug assessment in animal models

Physically active children in urban areas have high black carbon exposure, study finds

Physically active children in urban areas have high black carbon exposure, study finds

Gene therapy may be effective method for treating Niemann-Pick disease, type C1

Gene therapy may be effective method for treating Niemann-Pick disease, type C1

Scientists uncover new class of small molecules for fighting urinary tract infection

Scientists uncover new class of small molecules for fighting urinary tract infection

Study finds increased risk of pregnancy-associated stroke among young women

Study finds increased risk of pregnancy-associated stroke among young women

Adherence to medical therapy linked to better outcomes for patients who had heart procedures

Adherence to medical therapy linked to better outcomes for patients who had heart procedures

Screening for prolactin receptor could help improve TNBC prognosis and treatment

Screening for prolactin receptor could help improve TNBC prognosis and treatment

TxCell collaborates with UBC to develop CAR-Treg therapy to prevent graft rejection in organ transplantation

TxCell collaborates with UBC to develop CAR-Treg therapy to prevent graft rejection in organ transplantation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.